Valley National Advisers’s AtriCure ATRC Stock Holding History

Valley National Advisers’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-50	Closed	-$1K	–	769
2024 Q2	$1K	Buy	+50	New	+$1.15K	﹤0.01%	985
2024 Q1	–	Sell	-65	Closed	-$2K	–	1215
2023 Q4	$2K	Buy	65 +35	+117%	+$1.3K	﹤0.01%	913
2023 Q3	$1K	Buy	+30	New	+$1.46K	﹤0.01%	882

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Valley National Advisers's ATRC Position: Q3 2024 in Review

Valley National Advisers sold out of AtriCure (ATRC) in Q3 2024, closing a stake of 50 shares — an estimated $1K sold.

Valley National Advisers first reported a position in ATRC in Q3 2023 and held it in 3 quarters. The position peaked at $2K in Q4 2023. 201 funds tracked by Wall St. Rank hold ATRC as of Q3 2024.

Valley National Advisers reported no remaining AtriCure position as of Q3 2024 after selling out during the quarter.
Valley National Advisers sold 50 AtriCure shares in Q3 2024, an estimated $1K.
Valley National Advisers first reported a position in AtriCure in Q3 2023 and held it in 3 quarters.
Valley National Advisers's AtriCure position peaked at $2K in Q4 2023.
201 funds tracked by Wall St. Rank held AtriCure as of Q3 2024.

Based on Valley National Advisers's 13F filing for Q3 2024, filed 24 Oct 2024.